NO20005313L - Perforale sammensetninger av levosimendan med kontrollert frigjöring - Google Patents

Perforale sammensetninger av levosimendan med kontrollert frigjöring

Info

Publication number: NO20005313L
Authority: NO; Norway
Prior art keywords: perforated; compositions; controlled release; levosimendan; release levosimendan
Prior art date: 1998-04-23

Application number

NO20005313A

Other languages

English (en)

Other versions

NO329809B1 (no

NO20005313D0 (no

Inventor

Ilkka Larma

Maarit Baeckman

Saila Antila

Lasse Lehtonen

Original Assignee

Orion Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-23

Filing date

2000-10-20

Publication date

2000-11-21

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8551575&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20005313(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-10-20 Application filed by Orion Corp filed Critical Orion Corp

2000-10-20 Publication of NO20005313D0 publication Critical patent/NO20005313D0/no

2000-11-21 Publication of NO20005313L publication Critical patent/NO20005313L/no

2010-12-20 Publication of NO329809B1 publication Critical patent/NO329809B1/no

Links

238000013270 controlled release Methods 0.000 title 1
WHXMKTBCFHIYNQ-SECBINFHSA-N levosimendan Chemical compound C[C@@H]1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1 WHXMKTBCFHIYNQ-SECBINFHSA-N 0.000 title 1
229960000692 levosimendan Drugs 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Detergent Compositions (AREA)
Cosmetics (AREA)

NO20005313A 1998-04-23 2000-10-20 Perorale sammensetninger av levosimendan med kontrollert frigjoring NO329809B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FI980901A FI980901A7 (fi)	1998-04-23	1998-04-23	Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
PCT/FI1999/000329 WO1999055305A2 (en)	1998-04-23	1999-04-23	Controlled release peroral compositions of levosimendan

Publications (3)

Publication Number	Publication Date
NO20005313D0 NO20005313D0 (no)	2000-10-20
NO20005313L true NO20005313L (no)	2000-11-21
NO329809B1 NO329809B1 (no)	2010-12-20

Family

ID=8551575

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20005313A NO329809B1 (no)	1998-04-23	2000-10-20	Perorale sammensetninger av levosimendan med kontrollert frigjoring

Country Status (37)

Country	Link
US (1)	US7045147B1 (no)
EP (1)	EP1071397B1 (no)
JP (2)	JP4566402B2 (no)
KR (1)	KR100960597B1 (no)
CN (1)	CN1248691C (no)
AR (1)	AR019096A1 (no)
AT (1)	ATE258425T1 (no)
AU (1)	AU756641B2 (no)
BG (1)	BG64839B1 (no)
BR (1)	BR9909869A (no)
CA (1)	CA2329234C (no)
CO (1)	CO5070607A1 (no)
CZ (1)	CZ295194B6 (no)
DE (1)	DE69914472T2 (no)
DK (1)	DK1071397T3 (no)
EA (1)	EA002829B1 (no)
EE (1)	EE04220B1 (no)
ES (1)	ES2215379T3 (no)
FI (1)	FI980901A7 (no)
GE (1)	GEP20032906B (no)
HR (1)	HRP20000704B1 (no)
HU (1)	HUP0101458A3 (no)
ID (1)	ID27987A (no)
IL (2)	IL138951A0 (no)
MX (1)	MXPA00010367A (no)
NO (1)	NO329809B1 (no)
NZ (1)	NZ507453A (no)
PL (1)	PL197447B1 (no)
PT (1)	PT1071397E (no)
RS (1)	RS49962B (no)
SI (1)	SI1071397T1 (no)
SK (1)	SK285427B6 (no)
TR (1)	TR200003102T2 (no)
TW (1)	TWI224507B (no)
UA (1)	UA68376C2 (no)
WO (1)	WO1999055305A2 (no)
ZA (1)	ZA200005632B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI20011465A0 (fi) *	2001-07-04	2001-07-04	Orion Corp	Pyridatsinonijohdannaisen uusi käyttö
NZ542303A (en) *	2003-03-14	2008-12-24	Nirmal Mulye	A process for preparing sustained release tablets
FI20070521A7 (fi) *	2006-11-10	2008-05-11	Atacama Labs Oy	Rakeita, tabletteja ja rakeistusmenetelmä
US9320738B2 (en)	2008-06-30	2016-04-26	Tocagen Inc.	Formulations of 5-fluorocytosine and uses thereof
JP2014172850A (ja) *	2013-03-07	2014-09-22	Capsugel Belgium Nv	ハードカプセル製剤
CN105784895B (zh) *	2015-10-30	2018-05-22	成都欣捷高新技术开发有限公司	一种用高效液相色谱仪检测左西孟旦中杂质的方法
US11969424B2 (en)	2019-12-16	2024-04-30	Tenax Therapeutics, Inc.	Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ203684A (en)	1982-04-05	1986-06-11	Merck Sharp & Dohme	Granular formulation for the stabilization of unstable drugs or food supplements
US4716042A (en)	1986-06-16	1987-12-29	American Home Products Corporation	Stabilized coated aspirin tablets
GB8903130D0 (en) *	1989-02-11	1989-03-30	Orion Yhtymae Oy	Substituted pyridazinones
GB2251615B (en) *	1991-01-03	1995-02-08	Orion Yhtymae Oy	(-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
US5213811A (en) *	1991-09-13	1993-05-25	Sterling Drug Inc.	Oral sustained-release drug compositions
GB2266841A (en)	1992-05-06	1993-11-17	Orion Yhtymae Oy	Compounds for use as anti-ischemic medicaments
US5795909A (en) *	1996-05-22	1998-08-18	Neuromedica, Inc.	DHA-pharmaceutical agent conjugates of taxanes
GB9614098D0 (en) *	1996-07-05	1996-09-04	Orion Yhtymae Oy	Transdermal delivery of levosimendan
FI973804A7 (fi) *	1997-09-26	1999-03-27	Orion Yhtymae Oy	Levosimendaanin oraalisia koostumuksia
FI974578L (fi) *	1997-12-19	1999-06-20	Orion Yhtymae Oyj	Menetelmä levosimendaanin antamiseksi
FI980902A7 (fi) *	1998-04-23	1999-10-24	Orion Yhtymae Oyj	Levosimendaanin stabiileja koostumuksia

1998
- 1998-04-23 FI FI980901A patent/FI980901A7/fi unknown
1999
- 1999-03-26 CO CO99018533A patent/CO5070607A1/es unknown
- 1999-04-09 TW TW088105661A patent/TWI224507B/zh not_active IP Right Cessation
- 1999-04-22 AR ARP990101869A patent/AR019096A1/es active IP Right Grant
- 1999-04-23 TR TR2000/03102T patent/TR200003102T2/xx unknown
- 1999-04-23 JP JP2000545505A patent/JP4566402B2/ja not_active Expired - Fee Related
- 1999-04-23 US US09/673,794 patent/US7045147B1/en not_active Expired - Fee Related
- 1999-04-23 HU HU0101458A patent/HUP0101458A3/hu unknown
- 1999-04-23 EE EEP200000617A patent/EE04220B1/xx not_active IP Right Cessation
- 1999-04-23 CA CA002329234A patent/CA2329234C/en not_active Expired - Fee Related
- 1999-04-23 ID IDW20002367A patent/ID27987A/id unknown
- 1999-04-23 WO PCT/FI1999/000329 patent/WO1999055305A2/en not_active Ceased
- 1999-04-23 KR KR1020007011788A patent/KR100960597B1/ko not_active Expired - Fee Related
- 1999-04-23 AT AT99916941T patent/ATE258425T1/de not_active IP Right Cessation
- 1999-04-23 DK DK99916941T patent/DK1071397T3/da active
- 1999-04-23 CN CNB998064181A patent/CN1248691C/zh not_active Expired - Fee Related
- 1999-04-23 RS YUP-639/00A patent/RS49962B/sr unknown
- 1999-04-23 SI SI9930536T patent/SI1071397T1/xx unknown
- 1999-04-23 SK SK1554-2000A patent/SK285427B6/sk not_active IP Right Cessation
- 1999-04-23 DE DE69914472T patent/DE69914472T2/de not_active Expired - Lifetime
- 1999-04-23 EP EP99916941A patent/EP1071397B1/en not_active Expired - Lifetime
- 1999-04-23 NZ NZ507453A patent/NZ507453A/xx unknown
- 1999-04-23 IL IL13895199A patent/IL138951A0/xx active IP Right Grant
- 1999-04-23 PL PL344078A patent/PL197447B1/pl not_active IP Right Cessation
- 1999-04-23 MX MXPA00010367A patent/MXPA00010367A/es unknown
- 1999-04-23 HR HR20000704A patent/HRP20000704B1/xx not_active IP Right Cessation
- 1999-04-23 EA EA200001098A patent/EA002829B1/ru not_active IP Right Cessation
- 1999-04-23 UA UA2000116616A patent/UA68376C2/uk unknown
- 1999-04-23 CZ CZ20003780A patent/CZ295194B6/cs not_active IP Right Cessation
- 1999-04-23 BR BR9909869-5A patent/BR9909869A/pt not_active Application Discontinuation
- 1999-04-23 AU AU35246/99A patent/AU756641B2/en not_active Ceased
- 1999-04-23 PT PT99916941T patent/PT1071397E/pt unknown
- 1999-04-23 GE GEAP19995639A patent/GEP20032906B/en unknown
- 1999-04-23 ES ES99916941T patent/ES2215379T3/es not_active Expired - Lifetime
2000
- 2000-10-11 IL IL138951A patent/IL138951A/en not_active IP Right Cessation
- 2000-10-12 ZA ZA200005632A patent/ZA200005632B/en unknown
- 2000-10-20 NO NO20005313A patent/NO329809B1/no not_active IP Right Cessation
- 2000-11-17 BG BG104959A patent/BG64839B1/bg unknown
2010
- 2010-01-12 JP JP2010004367A patent/JP2010083900A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
ID27987A (id)	2001-05-03
CN1248691C (zh)	2006-04-05
WO1999055305A2 (en)	1999-11-04
PL344078A1 (en)	2001-09-24
CA2329234C (en)	2008-06-10
GEP20032906B (en)	2003-02-25
YU63900A (sh)	2003-07-07
BG64839B1 (bg)	2006-06-30
BG104959A (en)	2001-07-31
CZ295194B6 (cs)	2005-06-15
IL138951A0 (en)	2001-11-25
AR019096A1 (es)	2001-12-26
CZ20003780A3 (en)	2001-05-16
EP1071397A2 (en)	2001-01-31
CO5070607A1 (es)	2001-08-28
EP1071397B1 (en)	2004-01-28
SK285427B6 (sk)	2007-01-04
WO1999055305A3 (en)	1999-12-29
DE69914472T2 (de)	2004-11-11
HK1034032A1 (en)	2001-10-12
IL138951A (en)	2006-10-31
FI980901A0 (fi)	1998-04-23
RS49962B (sr)	2008-09-29
EA002829B1 (ru)	2002-10-31
AU3524699A (en)	1999-11-16
ATE258425T1 (de)	2004-02-15
KR20010071172A (ko)	2001-07-28
FI980901A7 (fi)	1999-10-24
MXPA00010367A (es)	2002-06-04
US7045147B1 (en)	2006-05-16
NO329809B1 (no)	2010-12-20
TR200003102T2 (tr)	2001-02-21
EA200001098A1 (ru)	2001-04-23
BR9909869A (pt)	2000-12-19
DE69914472D1 (de)	2004-03-04
HRP20000704A2 (en)	2001-04-30
JP4566402B2 (ja)	2010-10-20
EE04220B1 (et)	2004-02-16
JP2010083900A (ja)	2010-04-15
TWI224507B (en)	2004-12-01
NZ507453A (en)	2003-02-28
SK15542000A3 (sk)	2001-08-06
NO20005313D0 (no)	2000-10-20
JP2002512946A (ja)	2002-05-08
ZA200005632B (en)	2002-01-14
PT1071397E (pt)	2004-06-30
HRP20000704B1 (hr)	2009-11-30
SI1071397T1 (en)	2004-06-30
PL197447B1 (pl)	2008-03-31
ES2215379T3 (es)	2004-10-01
HUP0101458A3 (en)	2002-05-28
EE200000617A (et)	2002-06-17
KR100960597B1 (ko)	2010-06-07
DK1071397T3 (da)	2004-04-05
AU756641B2 (en)	2003-01-16
HUP0101458A2 (hu)	2002-03-28
CN1301163A (zh)	2001-06-27
UA68376C2 (en)	2004-08-16
CA2329234A1 (en)	1999-11-04

Legal Events

Date	Code	Title	Description
2011-11-28	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO20012857D0 (no)	2001-06-08	Galantaminsammensetning med kontrollert frigivelse
DK0922386T3 (da)	2004-06-07	Sammensætninger med reguleret frigivelse
NO20001585D0 (no)	2000-03-27	Orale sammensetninger av levosimendan
DK0758244T3 (da)	2002-02-11	Doseringsformer af azithromycin med styret frigivelse
DK1126826T3 (da)	2009-01-19	Multipartikel-modificeret-frigivelsessammensætning af methylphenidat
DK0954966T3 (da)	2003-10-20	Polymere sammensætninger med reguleret frigivelse
AR027907A1 (es)	2003-04-16	Composicion de liberacion controlada
PT945132E (pt)	2004-08-31	Composicao de ibuprofeno
NO995852D0 (no)	1999-11-29	Ny form av S-omeprazol
NO994946L (no)	1999-10-11	Formuleringer med forlenget frigivelse av erytromycinderivater
DE59706557D1 (de)	2002-04-11	Keramische Auskleidung
NO994790D0 (no)	1999-10-01	Estimering av permabilitet
IS4398A (is)	1996-12-17	Ný lyfjablanda til inntöku um munn sem inniheldurmagnesíumsalt af ómeprasóli
DE59706558D1 (de)	2002-04-11	Keramische Auskleidung
TR199903132A3 (tr)	2000-07-21	Metalosan bilesiklerinin aktive edici kompozisyonu.
NO20014301D0 (no)	2001-09-04	Sammensetninger med kontrollert frigivelse av betahistin
NO20005313L (no)	2000-11-21	Perforale sammensetninger av levosimendan med kontrollert frigjöring
DK0973769T3 (da)	2004-12-13	Fremgangsmåde til fremstilling af eprosartan
FI980222A0 (fi)	1998-01-30	Stycke av isoleringsaemne med en genomgaoende primaerstroemledning
DK0970073T3 (da)	2005-02-21	Fremgangsmåde til fremstilling af eprosartan
IS5821A (is)	2001-01-23	Kristalluð form af ósanetant
FI980902A7 (fi)	1999-10-24	Levosimendaanin stabiileja koostumuksia
NO20004583D0 (no)	2000-09-14	Krystallinsk form av paroxetine
NO994140L (no)	1999-10-28	Farmasöytisk sammensetning for den programerte frigivelse av deksfenfluramin
GC0000104A (en)	2005-06-29	Controlled release peroral compositions of levosimendan.